Natural immunity to cancer in humans
Section snippets
Advocacy for integrative cancer immunology
The tumor develops in a complex microenvironment comprising fibroblasts, endothelial cells, blood vessels, lymph vessels, immune cells, cytokines, chemokines, and products of cellular metabolism. By its components, the tumor microenvironment influences the growth of the tumor and its capacity to progress and to form metastases. In particular, the evolution of cancer reflects complex cellular and molecular interactions of the tumor with the immune system of the host [1•]. The characterization of
Immunosurveillance despite inflammation
In the literature there is an apparent conflict between the opposing host-protective and tumor-promoting roles of the immune system. Although this dichotomous view may facilitate the interpretation of data, maybe it is a too simplistic approach. We propose that the host-protecting action and inflammation can be overlapping immune responses, and that an orchestrated immune response against a developing tumor will contain different types of effector cells and molecules with co-existing
Lessons from human cancer analysis
In contrast to infiltration of cells responsible for chronic inflammation, the presence of high numbers of lymphocytes, especially T cells, has been reported as being of good prognosis in many cancer types: melanoma, non-Hodgkin lymphoma, non-small cell lung cancer, breast, ovarian, head, neck, esophagus, urothelial, and colorectal cancer [26, 32, 33•, 34, 35, 36, 37, 38, 39•, 40]. Regulatory T cells (Tregs) may modulate the immune function. However, increased tumor Tregs have been associated
The strongest prognostic factor for recurrence and overall survival: the immune contexture
Histopathological analysis of colorectal cancers shows that many tumors are infiltrated in variable quantities by inflammatory and lymphocytic cells. A closer look reveals that the latter are not randomly distributed, but rather seem to be organized as more or less dense infiltrations in different regions, that is the center of the tumor (CT) and at the forefront region of the tumor within the colonic mucosa, so called, the invasive margin (IM) of the tumor. We have extensively analyzed the
Global analysis of the intratumoral immune reaction: a breakthrough for patient prognosis
Analysis of immune cell densities was performed in regional lymph node metastases from Dukes’ stage C colorectal cancer. In patients with or without adjuvant radio/chemotherapy, the presence high numbers of CD8+ and CD45R0+ cells in regional lymph node correlated with increased survival time [52]. Furthermore, sentinel node from primary tumor and metastasis showed characteristics of tumor-reactive lymphocytes [53]. However, evaluation of T-cell subpopulations in lymph node is difficult in
A long-term memory against cancer?
Our results suggest that once human colorectal cancers become clinically detectable, the adaptive immune response plays a role in preventing tumor recurrence. Despite immunoediting mechanisms, the beneficial effect of the adaptive immunity may persist throughout tumor progression (stages II and III). Intratumoral T cells could modify tumor stroma or tumor cells in ways that attenuate their metastatic potential. The absence of microscopic evidence of early metastatic invasiveness within
Conclusions
Systems biology and biomolecular network reconstruction will be powerful approaches to uncover mechanisms associated with tumor progression and tumor recurrence. Integrative analyses evaluating the immune infiltrate in human cancers are of major importance. Compared to the immune contexture, no tumor parameter associated with survival has been reported to achieve a similarly high level of significance in colorectal cancer. This suggests that markers of the oncogenic process are closely
References and recommended reading
Papers of particular interest, published within the annual period of review, have been highlighted as:
• of special interest
•• of outstanding interest
Acknowledgements
We acknowledge all the scientists who made contributions to the area of research reviewed here that were not cited due to space constraints. The work performed in our laboratory was supported by grants from the Association pour la Recherche sur le Cancer (ARC), the National Cancer Institute (INCa), the Canceropole Ile de France, Ville de Paris, Inserm, and the European Commission (7FP, Geninca Consortium, grant number 202230).
References (65)
- et al.
ClueGO: a Cytoscape plug-in to decipher functionally grouped gene ontology and pathway annotation networks
Bioinformatics
(2009) - et al.
NF-kappaB: linking inflammation and immunity to cancer development and progression
Nat Rev Immunol
(2005) - et al.
IKKbeta couples hepatocyte death to cytokine-driven compensatory proliferation that promotes chemical hepatocarcinogenesis
Cell
(2005) - et al.
Cancer immunosurveillance and immunoediting: the roles of immunity in suppressing tumor development and shaping tumor immunogenicity
Adv Immunol
(2006) - et al.
Fatal melanoma transferred in a donated kidney 16 years after melanoma surgery
N Engl J Med
(2003) - et al.
Prognostic value of tumor infiltrating lymphocytes in the vertical growth phase of primary cutaneous melanoma
Cancer
(1996) - et al.
Different occurrence of CD8+, CD45R0+, and CD68+ immune cells in regional lymph node metastases from colorectal cancer as potential prognostic predictors
Int J Colorectal Dis
(2002) - et al.
Immune response against frameshift-induced neopeptides in HNPCC patients and healthy HNPCC mutation carriers
Gastroenterology
(2008) Cancer immunology
N Engl J Med
(2008)- et al.
The immune-body cytokine network defines a social architecture of cell interactions
Biol Direct
(2006)
Network modeling links breast cancer susceptibility and centrosome dysfunction
Nat Genet
Combined functional genomic maps of the C. elegans DNA damage response
Science
Functional profiling of the Saccharomyces cerevisiae genome
Nature
Systems biology approaches identify ATF3 as a negative regulator of Toll-like receptor 4
Nature
A comprehensive map of the toll-like receptor signaling network
Mol Syst Biol
Systems biology of innate immunity
Cell Immunol
Cytoscape: a software environment for integrated models of biomolecular interaction networks
Genome Res
Gene ontology: tool for the unification of biology. The Gene Ontology Consortium
Nat Genet
STRING: known and predicted protein–protein associations, integrated and transferred across organisms
Nucleic Acids Res
Biomolecular network reconstruction identifies T cell homing factors associated with survival in colorectal cancer
Gastroenterology
Cancer-related inflammation
Nature
Inflammation and cancer
Nature
JC virus and colorectal cancer: a possible trigger in the chromosomal instability pathways
Curr Opin Gastroenterol
JC virus mediates invasion and migration in colorectal metastasis
PLoS One
Cancer: an inflammatory link
Nature
Inflammation and cancer: back to Virchow?
Lancet
Nuclear factor-kappaB in cancer development and progression
Nature
De novo carcinogenesis promoted by chronic inflammation is B lymphocyte dependent
Cancer Cell
CD4(+) T cells regulate pulmonary metastasis of mammary carcinomas by enhancing protumor properties of macrophages
Cancer Cell
Vascular endothelial growth factor and its relationship to inflammatory mediators
Clin Cancer Res
The three Es of cancer immunoediting
Annu Rev Immunol
IFNgamma and lymphocytes prevent primary tumour development and shape tumour immunogenicity
Nature
Cited by (153)
The role of ion channels in the relationship between the immune system and cancer
2023, Current Topics in MembranesCurcumin encapsulation in functional PLGA nanoparticles: A promising strategy for cancer therapies
2022, Advances in Colloid and Interface ScienceEvaluating the Potential of T Cell Receptor Repertoires in Predicting the Prognosis of Resectable Non-Small Cell Lung Cancers
2020, Molecular Therapy Methods and Clinical Development